Related Experiment Video

Updated: Dec 18, 2025

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.2K

Can We Reduce Mortality of COVID-19 if We do Better in Glucose Control?

Mingyan Deng1, Ling Jiang2, Yan Ren3

  • 1West China-California Center for Predictive Intervention Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, China.

Medicine in Drug Discovery
|June 20, 2020
PubMed

Insights

The study highlights that diabetes patients have a higher risk of severe COVID-19 outcomes. High glucose may activate pathways that worsen viral infections, suggesting diabetes management could aid COVID-19 treatment.

Area of Science:

  • Infectious Diseases
  • Endocrinology
  • Immunology

Background:

  • COVID-19 (Coronavirus disease 2019) has caused significant global mortality.
  • Diabetic patients exhibit higher COVID-19 prevalence and lower survival rates.
  • High glucose levels may exacerbate viral infections by activating specific immune pathways.

Discussion:

  • High glucose levels in diabetes can damage cells and tissues.
  • Emerging research indicates high glucose activates interferon regulatory factor 1 (IRF1), potentially exacerbating influenza virus-induced cytokine storms.
  • This mechanism may explain the increased susceptibility and severity of COVID-19 in diabetic individuals.

Key Insights:

  • Diabetes is a critical comorbidity associated with poor COVID-19 outcomes.
  • High glucose-induced IRF1 activation is a potential pathway linking diabetes to severe COVID-19.
  • Understanding this link can inform targeted therapeutic strategies for diabetic COVID-19 patients.

Outlook:

  • Developing effective diabetes prevention and management strategies is crucial for mitigating COVID-19 severity.
  • Data-driven diabetes prediction models may offer novel approaches to identify at-risk individuals.
  • Further research into glucose metabolism and immune response in COVID-19 is warranted.

More Related Videos

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory10:03

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory

Published on: February 28, 2013

26.4K
Extracellular Glucose Depletion as an Indirect Measure of Glucose Uptake in Cells and Tissues Ex Vivo10:35

Extracellular Glucose Depletion as an Indirect Measure of Glucose Uptake in Cells and Tissues Ex Vivo

Published on: April 6, 2022

3.1K

Related Concept Videos

Overview of Carbohydrate Metabolism01:19

Overview of Carbohydrate Metabolism

Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
2.9K
Glucose Homeostasis: Regulation of Blood Glucose01:02

Glucose Homeostasis: Regulation of Blood Glucose

Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
3.5K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
775
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
6.0K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.2K
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
698